Table 1.
Baseline profiles classified by case group or control group
| Characteristics | Control group | AF group | P value (ASD) |
|---|---|---|---|
| NO. (%) | 9022 (66.7) | 4511 (33.3) | - |
| Demographic data | |||
| Women, n(%) | 4225 (46.83) | 2123 (47.06) | 0.798 (0.46%) |
| Ages (years) | 69 [61,76] | 69 [61,76] | 0.993( 0.10%) |
| BMI | 23.56 [21.45,25.55] | 23.62 [21.55,25.78] | 0.021 |
| Smoker, n(%) | 1300 (14.40) | 642 (14.23) | 0.781 (0.50%) |
| Alcohol taking status, n(%) | 1161 (12.86) | 583 (12.92) | 0.928 (0.16%) |
| SBP (mmHg) | 144 [130,159] | 138 [125,152] | < 0.001 |
| DBP (mmHg) | 84 [76,92] | 85 [76,94] | 0.013 |
| Medical history | |||
| Ischemic stroke, n(%) | 1647 (18.25) | 1129 (25.03) | < 0.001 |
| Type 2 diabetes mellitus, n(%) | 1908 (21.14) | 728 (16.14) | < 0.001 |
| Coronary heart disease, n(%) | 2431 (26.94) | 1215 (26.93) | 0.989 (0.24%) |
| Hypertension, n(%) | 5018 (55.62) | 2505 (55.53) | 0.922 (0.17%) |
| Medication on admission | |||
| β-receptor antagonists, n(%) | 2357 (26.12) | 3033 (67.24) | < 0.001 |
| Statin, n(%) | 4312 (47.79) | 2239 (49.63) | 0.043 |
| Laboratory values | |||
| Lp(a) (mg/dL) | 16.90 [8.80,33.29] | 15.95 [8.57,30.70] | < 0.001 |
| LDL-C (mmol/L) | 2.70 [2.12,3.29] | 2.35 [1.84,2.93] | < 0.001 |
| ApoA (mmol/L) | 1.18 [0.98,1.41] | 1.09 [0.92,1.32] | < 0.001 |
| ApoB (mmol/L) | 0.87 [0.70,1.07] | 0.77 [0.61,0.96] | < 0.001 |
| HDL-C (mmol/L) | 1.18 [0.97,1.44] | 1.11 [0.93,1.33] | < 0.001 |
| TC (mmol/L) | 4.63 [3.90,5.40] | 4.09 [3.41,4.81] | < 0.001 |
| TG (mmol/L) | 1.27 [0.92,1.86] | 1.09 [0.81,1.55] | < 0.001 |
| HCY (μmol/L) | 13.27 [11.13,16.18] | 13.78 [11.31,17.20] | < 0.001 |
| Albumin (g/L) | 39.48 [36.58,42.48] | 37.54 [35.03,40.22] | < 0.001 |
| CRP (mg/L) | 3.67 [2.15,8.78] | 4.03 [2.21,9.96] | < 0.001 |
| Blood glucose (mmol/L) | 5.58 [4.90,6.81] | 5.17 [4.62,6.14] | < 0.001 |
| Uric acid (μmol/L) | 338.03 [278.77,408.09] | 377.58 [310.25,458.53] | < 0.001 |
| Serum creatinine(μmol/L) | 72.00 [60.63,85.64] | 78.00 [65.21,91.99] | < 0.001 |
Continuous data are presented as the median [25, 75%]. The differences in the covariates included in PSM were evaluated by the P value and the absolute standardized mean difference (ASD)
ApoA Apolipoprotein A, ApoB Apolipoprotein B, BMI Body mass index, CHD Coronary heart disease, CRP C-reactive protein, DBP Diastolic blood pressure, HDL-C High-density lipoprotein cholesterol, HCY Homocysteine, LDL-C Low-density lipoprotein cholesterol, Lp(a) Lipoprotein (a), SBP Systolic blood pressure, TC Total cholesterol, TG Triglyceride